The utilisation of cardiac risk ratio and non-HDL cholesterol markers to assess cardiovascular risk in type 2 diabetes males with lowered serum DHT

The study investigated the relationship between cardiac risk markers and serum DHT levels in males with type 2 diabetes, focusing on the under-researched androgen, DHT. Conducted in India, the study involved 210 participants, split evenly between type 2 diabetes patients and controls. Researchers analyzed lipid parameters and serum DHT using conventional biochemical methods. The study aimed to explore the association of androgens with cardiovascular risk indicators, particularly in the context of male hypogonadism, which is linked to dyslipidemia, visceral obesity, and cardiovascular disorders.